Drugs and the placenta - A workshop report

Placenta

Volumn 24, Issue SUPPL. A, 2003, Pages

  Shiverick, K T ^a   Slikker Jr , W ^b   Rogerson, S J ^c   Miller, R K ^d  

^a UNIVERSITY OF FLORIDA   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACICLOVIR; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLOROQUINE; CORTICOSTEROID; CORTISONE; CROMOGLYCATE DISODIUM; DOPAMINE RECEPTOR BLOCKING AGENT; FANSIDAR; GLUCOCORTICOID; GLYCOPROTEIN IIB; HYDRALAZINE; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; LABETALOL; MAGNESIUM SULFATE; MALARIA VACCINE; MEFLOQUINE; NIFEDIPINE; PROGUANIL; QUININE; RECOMBINANT ERYTHROPOIETIN; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; UNINDEXED DRUG; VALACICLOVIR;

DOSE RESPONSE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; DRUG SAFETY; FEMALE; FETUS DEVELOPMENT; HERPES SIMPLEX; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALARIA; NAUSEA; PLACENTA; PLACENTAL TRANSFER; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; VOMITING; WORKSHOP;

EID: 0141614996     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0957     Document Type: Article

References (33)

1. Adibi S, Schenker S & Morse E (1996) Mechanism of clearance and transfer of dipeptides by perfused human placenta. Amer J Physiol, 271, E535-540.
2. Ambudkar S, Dey S, Hrycyna C, Ramachandra M, Pastan I & Gottesman M (1999) Biochemical, cellular and pharmacological aspects of the multidrug transport. Annu Rev Pharmacol Toxicol, 39, 361-398.
3. Audus K, Soares M & Hunt J (2002) Characteristics of the fetal/maternal interface with potential usefulness in the development of future immunological and pharmacological strategies. J Pharm Exp Therap, 301, 402-409.
4. Berg TG & Smith CV (2002) Pharmacologic therapy for peripartum emergencies. Clin Obstet Gynecol, 45, 125-135.
5. Belfort MA, Anthony J, Saade GR & Allen JC Jr (2003) A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med, 348, 304-311.
6. Caughey AB & Parer JT (2001) Tocolysis with beta-adrenergic agonists. Semin Perinatol, 25, 248-255.
7. Caughey AB & Parer JT (2002) Recommendations for repeat courses of antenatal corticosteroids: a decision analysis. Am J Obstet Gynecol, 186, 1221-1226.
8. Dekker G & Sibal B (2001) Primary, secondary and tertiary prevention of pre-eclampsia. Lancet, 357, 209-215.
9. Green MF (2003) Magnesium sulfate for preeclampsia. N Engl J Med, 348, 275-276.
10. Hansen WF & Yankowitz J (2002) Pharmacologic therapy for medical disorders during pregnancy. Clin Obstet Gynecol, 45, 136-152.
11. Kenyon SL, Taylor DJ & Tarnow-Mordi W (2001) Broad-spectrum antibitics for spontaneous preterm labor: the ORACLE II randomised trial. Lancet, 357, 981-990.
12. King JF, Flenady VJ, Papatsonis DN, Dekker GA & Carbonne B (2002) Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev, (2):CD002255.
13. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RAG, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Ghimpeni P, Taylor TE & Plowe CV (2002) Molecular markers for treatment failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone for falciparum malaria and a model for practical application in Africa. J Infect Dis, 185, 380-388.
14. Langer O, Conway DL, Berkus MD, Xenakis EM & Gonzales O (2000) A comparison of glyburide and insulin in women with gestational diabetes. N Engl J Med, 343, 1134-1138.
15. Leakey JEA, Althaus ZA, Bailey JR & Slikker W Jr (1985) Dexamethasone increases UDP-glucuronyltransferase activity towards bilirubin, estradiol and testosterone in feotal liver from rhesus monkey during late gestation. J Biochem, 225, 183-188.
16. Malek A, Sager R, Eckardt K, Bauer C & Schneider H (1994) Lack of transport of erythropoietin across the human placenta as studied by an In Vitro perfusion system. Pflugers Arch, 427, 157-161.
17. McGready R, Cho T, Hkirijaroen L, Simpson J, Chongsuphajaisiddhi T, White NJ & Nosten F (1998) Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy. Ann Trop Med Parasitol, 92, 643-653.
18. McGready R, Cho T, Keo NK, Thwai KL, Villegas L, Looareesuwan S, White NJ & Nosten F (2001) Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clin Infect Dis, 33, 2009-2016.
19. Miller RK, Mace K, Polliotti B, DeRita R, Hall W, & Treacy G (2003) Marginal Transfer of ReoPro™ (Abciximab) Compared with immunoglobulin G (F105), inulin and water in the perfused human placenta In Vitro. Placenta, In Press.
20. National Academy of Sciences Report (2000). Scientific Frontiers in Developmental Toxicology and Risk Assessment, Committee on Biologic Markers, Board on Environmental Studies and Toxicology, Commission on Life Sciences, National Research Council, National Academy Press, Washington.
21. Newnham JP & Ross TJ (2001) Antenatal glucocorticoids and growth: single versus multiple doses in animal and human studies. Semin Neonatol, 6, 285-292.
22. Parise ME, Ayisi J, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ & Steketee RW (1998) Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg, 59, 813-822.
23. Pavek P, Fendrich Z, Staud F, Malakova J, Brozmanova H, Laznicek H, Semecky V, Grundmann M & Palicka V (2001) Influence of P-glycoprotein on the transplacental passage of cyclosporine. J Pharm Sci, 90, 1583-1592.
24. Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango CG & Molyneux ME (2000) Intermittent sulphadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi 1997-1999. Trans R Soc Trop Med Hyg, 94, 549-553.
25. Schatz M (2001) The efficacy and safety of asthma medications during pregnancy. Semin Perinatol, 25, 145-152.
26. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N & Marsh K (1999) Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet, 353, 632-636.
27. Slikker W Jr (1987) Disposition of selected naturally occurring and synthetic steroids in the pregnant rhesus monkey. In Pharmacokinetics in Teratogenesis (Eds) Nau N & Scott W, pp. 149-176. Boca Raton, Florida: CRC Press Inc.
28. Slikker W Jr, Althaus ZR, Rowland JM, Hendrickx AG & Hill DE (1984) Comparison of the metabolism of cortisol and triamcinolone acetonide in the early, mid and late gestational age rhesus monkey (Macaca mulatta). Develop Pharmacol Ther, 7, 319-333.
29. Slikker W Jr, Althaus ZR, Rowland JM, Hill DE & Hendrickx AG (1982) Comparison of the transplacental pharmacokinetics of cortisol and triamcinolone acetonide in the rhesus monkey. J Pharmacol Exp Ther, 223(2), 368-374.
30. Smit J, Huisman M, van Tellingen O, Wiltshire H & Schenkel A (1999) Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest, 104, 1441-1447.
31. Steketee RW, Nahlen BL, Parise ME & Menendez C (2001) The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg, 64(Suppl), 28-35.
32. The Magpie Trial Collaboration Group (2002) Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a random mixed placebo-control trial. Lancet, 359, 1877-1890.
33. Thorp JM Jr, Hartmann KE, Berkman ND, Carey TS, Lohr KN, Gavin NI & Hasselblad V (2002) Antibiotic therapy for the treatment of preterm labor: a review of the evidence. Am J Obstet Gynecol, 186, 587-592.